www.uhasselt.be
DSpace

Document Server@UHasselt >
Research >
Research publications >

Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/3266

Title: Treatment with etidronate for men with idiopathic osteoporosis
Authors: GEUSENS, Piet
VANHOOF, Johan
RAUS, Jef
Dequeker, J
Nijs, J
Joly, J
Issue Date: 1997
Publisher: BRITISH MED JOURNAL PUBL GROUP
Citation: ANNALS OF THE RHEUMATIC DISEASES, 56(4). p. 280-280
Abstract: In a recent overview of current and potential future drug treatments for osteoporosis, the therapies for osteoporosis in men were discussed briefly.1 Osteoporosis in men is a heterogeneous disease of which 50% of the cases are classified as idiopathic osteoporosis (IOP).2 Long term data on treatment of men with IOP are not yet available. In an uncontrolled open study of 22 white men with IOP, we have studied prospectively, the effect of a two year treatment with cyclic etidronate (400 mg/d during two weeks every three months) and calcium (500 mg/d during 10 weeks every three months). All patients were extensively screened to exclude any causes of secondary osteoporosis, such as hypogonadism and hypercalciuria, or any other risk factors. Liver function tests were normal in all patients and there was no excessive alcohol consumption either. Bone mineral density (BMD) measurements were performed every six months in the lumbar spine (L2-L4) and in the femoral . . .
Notes: KATHOLIEKE UNIV LEUVEN,ARTHRIT & METAB BONE DIS RES UNIT,B-3001 LOUVAIN,BELGIUM.Geusens, P, LIMBURGS UNIV CTR,DR L WILLEMS INST,UNIV CAMPUS,B-3590 DIEPENBEEK,BELGIUM.
URI: http://hdl.handle.net/1942/3266
Link to publication: http://ard.bmj.com/cgi/content/extract/56/4/280a
ISI #: A1997WU81800017
ISSN: 0003-4967
Type: Journal Contribution
Appears in Collections: Research publications

Files in This Item:

There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.